Yunnan Jianfeng Held Special Meeting on Safety and Environmental Protection
Release time:
2020-07-22
Yunnan Jianfeng Held Special Meeting on Safety and Environmental Protection
News Recently, Yunnan Jianfeng Cement Company held a special meeting on safety and environmental protection to arrange and deploy the safety and environmental protection work in the next stage. At the
meeting, Zhou Jiping, general manager of Yunnan peak, put forward requirements for the next stage of safety and environmental protection work: for the production safety accidents of peer enterprises, we should attach great importance to them and earnestly learn lessons from the accidents. "" should investigate the potential accidents, immediately rectify and correct the potential accidents and signs found, and comprehensively strengthen the on-site safety management. Strictly implement the relevant systems of enterprise safety management, resolutely put an end to risky illegal operations and fluke psychology, and overcome carelessness; Continue to do a good job in the regular inspection of environmental and occupational health and safety management, and put an end to "three violations " , I .e. illegal command, illegal operation, violation of labor discipline and other bad behaviors; Guard security to strengthen "entrance guard management " , focus on special inspection and prevention of epidemic prevention and control, check and register personnel, materials and vehicles entering and leaving the factory, prohibit irrelevant personnel and vehicles from entering and leaving the factory, and park vehicles entering and leaving the designated place. Strictly abide by the speed limit for vehicles entering and leaving the factory and prohibit speeding. Safety and environmental protection work should be truly implemented, focusing on details and actual results. Improve political positions, implement the main responsibility of enterprises, and further consolidate safety management responsibilities, on-site safety management personnel and operators are required to earnestly study and implement the spirit of relevant documents and take effective measures to ensure safe production. At the same time, Zhou Jiping also stressed that according to the actual production of peak in Yunnan, key control links within the jurisdiction should be focused on control, especially the mine mining face slope treatment project should focus on inspection, strictly control safety risks, pay attention to implementation, speed up the progress of mine mining face slope treatment on the premise of ensuring safety, strive to complete the rectification and treatment by the end of the year, and successfully pass the acceptance. (Liu Fengbin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31